Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Proponents often highlight the potential for significant therapeutic benefits, principally in conditions where conventional medications have proven ineffective. However, this is to assess the considerable financial burden associated with CPI stem cell the